{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:40:46Z","timestamp":1760776846886,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.nmd.2010.11.004","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T04:42:47Z","timestamp":1293770567000},"page":"227-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reversible demyelinating neuropathy associated with renal cell carcinoma"],"prefix":"10.1016","volume":"21","author":[{"given":"Jeffrey A","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing J","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L","family":"Sufit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2010.11.004_b0005","unstructured":"American Cancer Society. Statistics for 2009. American Cancer Society. Available at: http:\/\/www.cancer.org\/docroot\/STT\/STT_0.asp."},{"key":"10.1016\/j.nmd.2010.11.004_b0010","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5858\/133.7.1026","article-title":"Recent developments in the pathology of renal tumors: morphology and molecular characteristics of select entities","volume":"133","author":"Yan","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.nmd.2010.11.004_b0015","first-page":"3","article-title":"Pathology, biology, and clinical staging of renal cell carcinoma","volume":"16","author":"Stenzl","year":"1989","journal-title":"Semin Oncol"},{"key":"10.1016\/j.nmd.2010.11.004_b0020","first-page":"163","article-title":"Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma","volume":"4","author":"Palapattu","year":"2002","journal-title":"Rev Urol"},{"key":"10.1016\/j.nmd.2010.11.004_b0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5347(17)61741-5","article-title":"The changing concept of hypernephroma","volume":"104","author":"Warren","year":"1970","journal-title":"J Urol"},{"key":"10.1016\/j.nmd.2010.11.004_b0030","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/milmed\/167.12.986","article-title":"Life-threatening polyneuropathy heralding renal cell carcinoma","volume":"167","author":"Roy","year":"2002","journal-title":"Mil Med"},{"key":"10.1016\/j.nmd.2010.11.004_b0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1742-1241.1990.tb10805.x","article-title":"Renal cell carcinoma and peripheral neuropathy","volume":"44","author":"Battcock","year":"1990","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.nmd.2010.11.004_b0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(63)93060-5","article-title":"Polyneuritis and renal cell carcinoma","volume":"2","author":"Swan","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2010.11.004_b0045","first-page":"99","article-title":"Renal cell carcinoma with sensorimotor neuropathy","volume":"90","author":"Brechkten","year":"1997","journal-title":"Tenn Med"},{"key":"10.1016\/j.nmd.2010.11.004_b0050","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0002-9343(03)00125-6","article-title":"Subacute motor weakness and left renal mass","volume":"114","author":"Alimonti","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.nmd.2010.11.004_b0055","first-page":"1723","article-title":"Case records of the Massachusetts General Hospital: case 50 \u2013 1991","volume":"325","author":"Leifer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2010.11.004_b0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3346\/jkms.1992.7.2.167","article-title":"Progressive atypical peripheral neuropathy following nephrectomy in a patient with renal cell carcinoma","volume":"7","author":"Kim","year":"1992","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.nmd.2010.11.004_b0065","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1378\/chest.115.3.899","article-title":"A reversible cause of hypercapnic respiratory failure: lower motor neuronopathy associated with renal cell carcinoma","volume":"115","author":"Forman","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.nmd.2010.11.004_b0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000163053","article-title":"Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma","volume":"18","author":"Turk","year":"2009","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.nmd.2010.11.004_b0075","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/ana.410270706","article-title":"Electrophysiology in Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Cornblath","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2010.11.004_b0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu\u2013associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71 patients","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nmd.2010.11.004_b0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/brain\/awf006","article-title":"Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients","volume":"125","author":"Camdessanch\u00e9","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2010.11.004_b0090","first-page":"200","article-title":"Relapsing peripheral neuropathy in association with renal carcinoma","volume":"60","author":"Lloyd","year":"1973","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.nmd.2010.11.004_b0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/gcc.2870030403","article-title":"Cytogenetics of papillary renal cell tumors","volume":"3","author":"Kovacs","year":"1991","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.nmd.2010.11.004_b0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/81.7.527","article-title":"Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis","volume":"81","author":"Kovas","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nmd.2010.11.004_b0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2010.11.004_b0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3346\/jkms.2006.21.4.672","article-title":"MET expression in sporadic renal cell carcinomas","volume":"21","author":"Choi","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.nmd.2010.11.004_b0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/6310","article-title":"Hepatocyte growth factor, a versatile signal for developing neurons","volume":"2","author":"Maina","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nmd.2010.11.004_b0120","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1074\/jbc.272.8.5187","article-title":"Hepatocyte growth factor promotes motor neuron survival and synergizes with ciliary neurotrophic factor","volume":"272","author":"Wong","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2010.11.004_b0125","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1101\/gad.11.24.3341","article-title":"Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons","volume":"11","author":"Maina","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.nmd.2010.11.004_b0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","article-title":"The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain\u2013Barr\u00e9 syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Sainaghi","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.nmd.2010.11.004_b0135","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1038\/onc.2009.186","article-title":"Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response","volume":"28","author":"Balamurugan","year":"2009","journal-title":"Oncogene"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610006607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610006607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:59:01Z","timestamp":1760774341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896610006607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0960896610006607"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2010.11.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversible demyelinating neuropathy associated with renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2010.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}